PMI stock news · Picard Medical, Inc.
Get alerts for PMI
Follow Picard Medical, Inc. (PMI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PMIPicard Medical, Inc. signs a big agreement to swap warrants for stock.
NeutralPicard Medical issued 200,000 shares to end rights to buy its stock and received no cash. The exchange also ended certain claims, so the filing points neither up nor down.
12 health care stocks changed a lot after the market closed on Tuesday.
NeutralPicard Medical shares rose 8.89%, but the report gives no new company results or business news. The share move alone does not change its business outlook.
12 health care stocks are changing a lot before the market opens on Friday.
NeutralPicard Medical shares rose 24.49% in Friday's pre-market session. The article gives no company news, so this does not change its business outlook.
12 health care stocks changed a lot in prices during Thursday's after-hours trading.
NeutralPicard Medical shares rose 11.99% after hours. The article gives no company update or reason, so this move alone does not change its business outlook.
12 health care stocks changed a lot in prices after the market closed on Tuesday.
NeutralPicard Medical shares fell about 10% after hours. The article gives no business reason for the move, so it does not change what we know about the company.
12 health care stocks are changing a lot during Tuesday's trading.
NeutralPicard Medical shares rose 25% during Tuesday's session, but the story gives no business update, so the move alone does not change its outlook.
Picard Medical, Inc. says it has a new financial responsibility worth $1 million.
Bad for PMIPicard Medical issued $1.0 million in notes that must be repaid or can turn into shares and warrants. The added debt and possible new shares make this unfavorable for existing owners.
What is Driving the Rise of Picard Medical Shares on Monday?
Good for PMIPicard Medical's stock surged over 27% following a strong earnings report that showed a nearly doubling of revenue compared to expectations, despite a larger-than-expected loss. The company's advancements in its artificial heart program and improved gross profit margins further bolster investor confidence.